Cash and Cash Equivalents, at Carrying Value of EUPRAXIA PHARMACEUTICALS INC. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary: EUPRAXIA PHARMACEUTICALS INC. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
EUPRAXIA PHARMACEUTICALS INC. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2025 was $80,563,482, a 143% increase year-over-year.
Source SEC data: View on sec.gov

Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)

Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

EUPRAXIA PHARMACEUTICALS INC. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$80,563,482	+$47,462,188	+143%	31 Dec 2025	40-F	13 Mar 2026	2025	FY
Q4 2024	$33,101,294	+$13,759,538	+71%	31 Dec 2024	40-F	13 Mar 2026	2025	FY
Q4 2023	$19,341,756	+$1,078,367	+5.9%	31 Dec 2023	40-F	20 Mar 2025	2024	FY
Q4 2022	$18,263,389			31 Dec 2022	40-F	01 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.